Concise syntheses of 2-aminoindans via indan-2-ol

被引:25
作者
Göksu, S [1 ]
Seçen, H [1 ]
机构
[1] Ataturk Univ, Dept Chem, Fac Arts & Sci, TR-25240 Erzurum, Turkey
关键词
2-aminoindans; synthesis; 2-azidoindans; 2-indanols; Mitsunobu reactions; dopamine;
D O I
10.1016/j.tet.2005.04.069
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
2-Amino-5,6-dimethoxyindan hydrochloride was synthesized in seven steps and with an overall yield of 48%. Indan-2-ol was converted to 5,6-dibromo-indan-2-ol in three steps by acetylation, electrophilic bromination and deacetylation. Dimethoxylation of 5,6-dibromoindan-2-ol with NaOCH3 in the presence of CuI gave 5,6-dimethoxy-indan-2-ol, which was converted to 2-amino-5,6-dimethoxyindan hydrochloride by azidation, followed by Pd-C catalyzed hydrogenation. Similarly, 2-amino-5-bromoindan was synthesized in five steps and with an overall yield of 50%. Indan-2-ol was converted to 2-aminoindan by azidation followed by Pd-C catalyzed hydrogenation. The reaction of 2-aminoindan with 2.5 equiv Br-2 afforded 2-amino-5,6-dibromoindan. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6801 / 6807
页数:7
相关论文
共 31 条
[1]   The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine [J].
Baker, LE ;
Svensson, KA ;
Garner, KJ ;
Goodwin, AK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 358 (02) :101-109
[2]   Stereoselective benzylic hydroxylation of 2-substituted indanes using toluene dioxygenase as biocatalyst [J].
Bowers, NI ;
Boyd, DR ;
Sharma, ND ;
Goodrich, PA ;
Groocock, MR ;
Blacker, AJ ;
Goode, P ;
Dalton, H .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (11) :1453-1461
[3]  
Cannon J G, 1985, Prog Drug Res, V29, P303
[4]   CONFORMATIONALLY RESTRICTED CONGENERS OF DOPAMINE DERIVED FROM 2-AMINOINDAN [J].
CANNON, JG ;
PEREZ, JA ;
BHATNAGAR, RK ;
LONG, JP ;
SHARABI, FM .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (12) :1442-1446
[5]   Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A [J].
Christian, AJ ;
Goodwin, AK ;
Baker, LE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (03) :371-377
[6]   Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system [J].
Dannenfelser, RM ;
He, H ;
Joshi, Y ;
Bateman, S ;
Serajuddin, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) :1165-1175
[7]   The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT [J].
Depoortere, R ;
Perrault, G ;
Sanger, DJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 65 (01) :31-34
[8]  
FIESER LF, 1967, REAGENTS ORGANIC SYN, V1, P446
[9]   Effects of the putative dopamine D-3 receptor antagonist PNU 99194A on motor behavior and emotional reactivity in C57BL/6J mice [J].
Gendreau, PL ;
Petitto, JM ;
Schnauss, R ;
Frantz, KJ ;
VanHartesveldt, C ;
Gariepy, JL ;
Lewis, MH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 337 (2-3) :147-155
[10]   Double Mitsunobu reactions of cis-cycloalk-2-ene-1,4-diols and 3,4-epoxycycloalkenes:: Rearrangements of allylic diazides [J].
Göksu, S ;
Ozalp, C ;
Seçen, H ;
Sütbeyaz, Y ;
Saripinar, E .
SYNTHESIS-STUTTGART, 2004, (17) :2849-2854